Global Epinephrine Autoinjector Market 2015-2019

エピネフリン・オートインジェクターの世界市場2015-2019

◆タイトル:Global Epinephrine Autoinjector Market 2015-2019
◆商品コード:IRTNTR5520
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年3月25日
◆ページ数:89
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、エピネフリン・オートインジェクターの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、エピネフリン・オートインジェクターの世界市場規模及び予測、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Epinephrine
Epinephrine, commonly known as adrenaline, is a hormone secreted by the medulla of the adrenal gland and circulated through the bloodstream. It acts as a neurotransmitter that responds to brain signals. These signals trigger responses such as threat, excitement, danger, emotion, and stress, which stimulate the adrenal gland to secrete epinephrine in response to the changes in the body. Adrenaline prepares the body to fight against anaphylactic shock that occurs due to allergic reactions, cardiac arrest, asthma, and superficial bleeding. Chemically synthesized epinephrine is usually administered to patients suffering from the above symptoms because it stimulates the heartbeat, increases blood pressure, relaxes involuntary muscles, and constricts small blood vessels. Epinephrine is also used with local anesthetic agents such as bupivacaine and lidocaine to enhance the effect of anesthesia. It is available in injection form as well as aerosol form for inhalation.

Epinephrine auto-injector is an emergency injection (“shot”) of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.

TechNavio’s analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.12 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Epinephrine Auto-injector market for the period 2015–2019. To calculate the market size, the report considers revenue generated from sales of various epinephrine auto-injectors that are available in the market.
TechNavio’s report, Global Epinephrine Auto-injector Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• ALK Abello
• Amedra Pharmaceuticals
• Lincoln Medical
• Mylan
• Sanofi

[Other Prominent Vendors]
• Adamis Pharmaceuticals
• Antares Pharma
• Hospira
• Intelliject
• Teva Pharmaceutical Industries

[Market Driver]
• Increased Prevalence of Allergies
• For a full, detailed list, view our report

[Market Challenge]
• Adverse Side Effects
• For a full, detailed list, view our report

[Market Trend]
• Development of CFC-free Epinephrine Auto-injectors
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Overview: Epinephrine Autoinjector

07.Market Overview

08.Key Factors Influencing Development of Epinephrine Autoinjectors

09.Market Landscape
09.1 Market Size and Forecast
09.2 Epinephrine Autoinjector Market in US
Market Size and Forecast
09.3 Five Forces Analysis

10.Geographical Segmentation
10.1 Global Epinephrine Autoinjector Market by Geographical Segmentation 2014-2019

11.Rate of Incidence and Prevalence

12.Competitive Landscape of Epinephrine Autoinjectors

13.Product Description
13.1.1 EpiPen
13.1.2 Jext
13.1.3 Adrenaclick
13.1.4 Anapen
13.1.5 Auvi-Q

14.Product Landscape

15.Buying Criteria

16.Market Growth Drivers

17.Drivers and their Impact

18.Market Challenges

19.Impact of Drivers and Challenges

20.Market Trends

21.Trends and their Impact

22.Vendor Landscape
22.1 Competitive Scenario
22.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2014
22.2.1 ALK-Abelló
22.2.2 Amedra Pharmaceuticals
22.2.3 Lincoln Medical
22.2.4 Mylan
22.2.5 Sanofi
22.3 Other Prominent Vendors

23.Key Vendor Analysis
23.1 ALK-Abelló
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Product Segmentation by Revenue 2014
23.1.4 Product Segmentation by Revenue 2013 and 2014
23.1.5 Geographical Segmentation by Revenue 2014
23.1.6 Business Strategy
23.1.7 Recent Developments
23.1.8 SWOT Analysis
23.2 Amedra Pharmaceuticals
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 SWOT Analysis
23.3 Lincoln Medical
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Geographical Presence
23.3.4 Recent Developments
23.3.5 SWOT Analysis
23.4 Mylan
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2011-2013
23.4.5 Geographical Segmentation by Revenue 2013
23.4.6 Business Strategy
23.4.7 Recent Developments
23.4.8 SWOT Analysis
23.5 Sanofi SA
23.5.1 Key Facts
23.5.2 Business Description
23.5.3 Business Segmentation
23.5.4 Revenue by Business Segmentation
23.5.5 Revenue Comparison 2012 and 2013
23.5.6 Sales by Geography
23.5.7 Business Strategy
23.5.8 Key Developments
23.5.9 SWOT Analysis

24.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Epinephrine Autoinjectors
Exhibit 4: Snapshot of Global Epinephrine Autoinjector Market 2014
Exhibit 5: Factors Influencing Development of Epinephrine Autoinjectors
Exhibit 6: Global Epinephrine Autoinjector Market 2014-2019 (US$ million)
Exhibit 7: Epinephrine Autoinjector Market in US 2014-2019 (US$ million)
Exhibit 8: Segmentation of Global Epinephrine Autoinjector Market by Geography 2014
Exhibit 9: Leading Brands in Global Epinephrine Autoinjectors Market
Exhibit 10: Design of EpiPen
Exhibit 11: EpiPen Administration Technique
Exhibit 12: Different Doses for Jext Autoinjector
Exhibit 13: Jext Administration Technique
Exhibit 14: Adrenaclick Administration Technique
Exhibit 15: Anapen Administration Technique
Exhibit 16: Auvi-Q Administration Technique
Exhibit 17: Leading Vendors in Global Epinephrine Autoinjector Market 2014
Exhibit 18: ALK-Abelló: Total Revenue by Product Line 2014
Exhibit 19: ALK-Abelló: Jext
Exhibit 20: Amedra Pharmaceuticals: Adrenaclick
Exhibit 21: Adrenaclick: Sales Revenue in US 2010-2013 (US$ million)
Exhibit 22: Lincoln Medical: Anapen
Exhibit 23: Mylan: EpiPen
Exhibit 24: EpiPen Autoinjector: Landscape
Exhibit 25: Sanofi: Key Facts and Figures 2014
Exhibit 26: Auvi-Q: Sales Revenue Q1-Q4 2014 (US$ million)
Exhibit 27: Sanofi: Auvi-Q
Exhibit 28: ALK-Abelló: Product Segmentation by Revenue 2014
Exhibit 29: ALK-Abelló: Product Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 30: ALK-Abelló: Geographical Segmentation by Revenue 2014
Exhibit 31: Lincoln Medical : Geographical Presence
Exhibit 32: Global Epinephrine Autoinjector Market: Business Segmentation by Revenue 2013
Exhibit 33: Global Epinephrine Autoinjector Market: Business Segmentation by Revenue 2011-2013 (US$ billion)
Exhibit 34: Global Epinephrine Autoinjector Market: Geographical Segmentation by Revenue 2013
Exhibit 35: Sanofi SA: Business Segmentation
Exhibit 36: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 37: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 38: Sanofi SA: Sales Revenue by Geographical Segmentation 2013



【掲載企業】

ALK Abello , Amedra Pharmaceuticals , Lincoln Medical , Mylan , Sanofi, Adamis Pharmaceuticals, Antares Pharma, Hospira, Intelliject, Teva Pharmaceutical Industries

【資料のキーワード】

エピネフリン自動注入、エピネフリン(アドレナリン)・オートインジェクター、エピペン、医療デバイス、医薬品

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[エピネフリン・オートインジェクターの世界市場2015-2019] (Global Epinephrine Autoinjector Market 2015-2019 / IRTNTR5520)販売に関する免責事項
[エピネフリン・オートインジェクターの世界市場2015-2019] (Global Epinephrine Autoinjector Market 2015-2019 / IRTNTR5520)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆